论文部分内容阅读
全球范围内,2型糖尿病的发病率逐年增高。血管紧张素Ⅱ受体抑制剂(ARB)类药物在预防糖尿病肾病中的作用尚未有报道,本研究旨在探讨厄贝沙坦在预防糖尿病肾病中的作用,报告如下。资料与方法 1一般资料:选择自2008年10月～2010年3月我院内科2型糖尿病患者58例,年龄30～75岁,2型糖尿病病程<3年,应用口服降糖药物和(或)胰岛素治疗,空腹血糖<8.0mmol/L,HbA1c<7%,均无高血压病病史。排除急性炎症、
Globally, the incidence of type 2 diabetes increased year by year. The role of angiotensin II receptor inhibitor (ARB) in the prevention of diabetic nephropathy has not been reported. This study was designed to investigate the role of irbesartan in the prevention of diabetic nephropathy. Materials and Methods 1 General Information: From October 2008 to March 2010 in our hospital 58 patients with type 2 diabetes mellitus, aged 30 to 75 years, type 2 diabetes course of <3 years, the application of oral antidiabetic drugs and (or ) Insulin treatment, fasting blood glucose <8.0mmol / L, HbA1c <7%, no history of hypertension. Exclude acute inflammation,